Lotte Holdings Healthcare and Biopharmaceutical CVC
Overview
Lotte Holdings Healthcare and Biopharmaceutical CVC is the corporate venture capital arm of LOTTE Holdings that invests in biopharmaceuticals and next-generation modalities.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Cartography Biosciences | Oct 2025 | Series B | Co-investor |
Key People
Joon Paek
Chief Bio Innovation Officer, Managing Partner, Healthcare & Biopharamaceutical CVC
Yusuke Yamada
Vice President ONE LOTTE Officer, Corporate Business Development Div, Corporate Strategy HQ, Investment Committee Of LOTTE Healthcare And Biopharmaceutical Corporate Venture Capital
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Lotte Holdings Healthcare and Biopharmaceutical CVC based?
Lotte Holdings Healthcare and Biopharmaceutical CVC is headquartered in Tokyo, Japan.
When was Lotte Holdings Healthcare and Biopharmaceutical CVC founded?
Lotte Holdings Healthcare and Biopharmaceutical CVC was founded in 2024.
How many portfolio companies does Lotte Holdings Healthcare and Biopharmaceutical CVC have?
Lotte Holdings Healthcare and Biopharmaceutical CVC has 1 portfolio company in Caplight's dataset.
What are some companies in Lotte Holdings Healthcare and Biopharmaceutical CVC's portfolio?
Portfolio companies visible on Caplight include Cartography Biosciences.
What was Lotte Holdings Healthcare and Biopharmaceutical CVC's most recent investment shown here?
Lotte Holdings Healthcare and Biopharmaceutical CVC's most recent investment in this portfolio sample was in Cartography Biosciences in 2025.
What sectors does Lotte Holdings Healthcare and Biopharmaceutical CVC focus on?
Lotte Holdings Healthcare and Biopharmaceutical CVC focuses on Healthcare & Life Sciences.
What company stages does Lotte Holdings Healthcare and Biopharmaceutical CVC focus on?
Lotte Holdings Healthcare and Biopharmaceutical CVC typically invests at the Mid stage.